Xiang Li

Xiang Li is a Principal Scientist II at Roche, focusing on Molecular Point-of-Care assay development and technology innovation. Prior to this, Xiang Li was a Scientist at Sherlock Biosciences, working on developing accurate, fast, and affordable molecular testing platforms. Xiang Li holds a PhD from The University of Texas at Austin and has completed postdoctoral research at Harvard University and Harvard Medical School after obtaining a BS degree from Nanjing University.